Evidence map›Paper›PMID 22510623›Full record

ReviewClinical obstetrics and gynecology2012

Serum biomarkers for detecting ectopic pregnancy.

Mary E Rausch, Kurt T Barnhart

Registry-linked trialAbstract readReview
In one paragraph

Review in Clinical obstetrics and gynecology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05591599 (Diagnostic Value of Calponin 2 in Identifying Tubal Pregnancies), which is not on this map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05591599 unknown statusnot on this mapstarted 2022, after this paper: background citation

Diagnostic Value of Calponin 2 in Identifying Tubal Pregnancies

TypeobservationalSponsorMỹ Đức HospitalRan2022 to 2025Enrolled407ConditionsTubal PregnancyArmscalponin 2
3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Metabolomic identification of novel diagnostic biomarkers in ectopic pregnancy.Metabolomics : Official journal of the Metabolomic Society · 2019
    Article
  8. Article
  9. Congenital Transmission ofFrontiers in microbiology · 2019
    Review
  10. Methotrexate Therapy for Ectopic Pregnancies: A Tertiary Center Experience.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2018
    Article
  11. Developing a deeper insight into reproductive biomarkers.Clinical and experimental reproductive medicine · 2017
    Review
  12. Article
  13. No increase in free fetal DNA level in ectopic pregnancy: A preliminary study.Turkish journal of obstetrics and gynecology · 2017
    Article
  14. Tale of 2 pregnancies: Heterotopic pregnancy in a spontaneous cycle.Canadian family physician Medecin de famille canadien · 2016
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mary E RauschDepartment of Obstetrics and Gynecology, Center for Human Reproduction, North Shore University Hospital, Manhasset, New York, USA. mrausch@nshs.edu
Kurt T Barnhart

Funding

RISK FACTORS AS PREDICTORS OF ECTOPIC PREGNANCYR01HD036455 · NICHD · UNIVERSITY OF PENNSYLVANIA · PI BARNHART, KURT T · 1999 to 2010
$4.1M
Midcareer investigator award in patient oriented researchK24HD060687 · NICHD · UNIVERSITY OF PENNSYLVANIA · PI BARNHART, KURT T · 2009 to 2014
$956k
NICHD NIH HHS K24 HD060687NICHD NIH HHS K24HD060687NICHD NIH HHS R01 HD036455NICHD NIH HHS R01-HD036455
6 · The paper itself

Abstract

Unless an ectopic pregnancy is visible by ultrasound, diagnosis can be a challenge. Differentiating ectopic pregnancies from intrauterine pregnancies can be impossible without intervention or follow-up. This poses a clinical dilemma to the practitioner given the inherent danger to the mother of tubal rupture of an ectopic pregnancy versus the fear of intervening in the case of a desired pregnancy without certainty of diagnosis. Early diagnostic modalities are clearly lacking, and serum biomarkers are currently being investigated as a solution to need for a rapid and accurate test for ectopic pregnancy.

Indexed as

ActivinsADAM12 ProteinADAM ProteinsBiomarkersCA-125 AntigenChorionic GonadotropinCreatine KinaseEstradiolFemaleGlycodelinGlycoproteinsHumansInhibinsInterleukin-6Interleukin-8Leukemia Inhibitory Factoractivin Aactivin BActivinsADAM12 ProteinADAM12 protein, humanADAM ProteinsBiomarkersCA-125 AntigenChorionic GonadotropinCreatine KinaseEstradiolGlycodelinGlycoproteinsinhibin AInhibinsInterleukin-6Interleukin-8Leukemia Inhibitory FactorMembrane ProteinsMyoglobinMyosin Heavy ChainsPAEP protein, humanPlacental LactogenPregnancy-Associated Plasma Protein-APregnancy ProteinsPregnancy-Specific beta 1-GlycoproteinsProgesteroneProteomeRelaxinReninTumor Necrosis Factor-alphaVascular Endothelial Growth Factor A

Identifiers

PMID22510623
PMCPMC3329643

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.